BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 35753528)

  • 1. The EEF1AKMT3/MAP2K7/TP53 axis suppresses tumor invasiveness and metastasis in gastric cancer.
    Hong YH; Aziz N; Park JG; Lee D; Kim JK; Kim SA; Choi W; Lee CY; Lee HP; Huyen Trang HT; Kim HG; Jeon YJ; Kim B; Kim Y; Kim KH; Yoo BC; Han JW; Parameswaran N; Kim JH; Hur H; Cho JY
    Cancer Lett; 2022 Sep; 544():215803. PubMed ID: 35753528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metastasis suppressor protein 1 regulated by PTEN suppresses invasion, migration, and EMT of gastric carcinoma by inactivating PI3K/AKT signaling.
    Wang H; Zhao Y; Cao L; Zhang J; Wang Y; Xu M
    J Cell Biochem; 2019 Mar; 120(3):3447-3454. PubMed ID: 30246429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SMURF1 promotes the proliferation, migration and invasion of gastric cancer cells.
    Tao Y; Sun C; Zhang T; Song Y
    Oncol Rep; 2017 Sep; 38(3):1806-1814. PubMed ID: 28731194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pseudogene-derived long non-coding RNA SFTA1P suppresses cell proliferation, migration, and invasion in gastric cancer.
    Ma H; Ma T; Chen M; Zou Z; Zhang Z
    Biosci Rep; 2018 Apr; 38(2):. PubMed ID: 29523596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic inactivation of paired box gene 5, a novel tumor suppressor gene, through direct upregulation of p53 is associated with prognosis in gastric cancer patients.
    Li X; Cheung KF; Ma X; Tian L; Zhao J; Go MY; Shen B; Cheng AS; Ying J; Tao Q; Sung JJ; Kung HF; Yu J
    Oncogene; 2012 Jul; 31(29):3419-30. PubMed ID: 22105368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PKNOX2 suppresses gastric cancer through the transcriptional activation of IGFBP5 and p53.
    Zhang L; Li W; Cao L; Xu J; Qian Y; Chen H; Zhang Y; Kang W; Gou H; Wong CC; Yu J
    Oncogene; 2019 Jun; 38(23):4590-4604. PubMed ID: 30745575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRIM59 is up-regulated in gastric tumors, promoting ubiquitination and degradation of p53.
    Zhou Z; Ji Z; Wang Y; Li J; Cao H; Zhu HH; Gao WQ
    Gastroenterology; 2014 Nov; 147(5):1043-54. PubMed ID: 25046164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding RNA VCAN-AS1 contributes to the progression of gastric cancer via regulating p53 expression.
    Feng L; Li J; Li F; Li H; Bei S; Zhang X; Yang Z
    J Cell Physiol; 2020 May; 235(5):4388-4398. PubMed ID: 31637706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. m
    Xie JW; Huang XB; Chen QY; Ma YB; Zhao YJ; Liu LC; Wang JB; Lin JX; Lu J; Cao LL; Lin M; Tu RH; Zheng CH; Huang CM; Li P
    Mol Cancer; 2020 Jul; 19(1):114. PubMed ID: 32650804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TP53 genomic status regulates sensitivity of gastric cancer cells to the histone methylation inhibitor 3-deazaneplanocin A (DZNep).
    Cheng LL; Itahana Y; Lei ZD; Chia NY; Wu Y; Yu Y; Zhang SL; Thike AA; Pandey A; Rozen S; Voorhoeve PM; Yu Q; Tan PH; Bay BH; Itahana K; Tan P
    Clin Cancer Res; 2012 Aug; 18(15):4201-12. PubMed ID: 22675170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated Notch-1 expression promotes the lymph node metastasis of gastric cancer and the Notch-1-PTEN-ERK1/2 signalling axis promotes the progression of gastric cancer.
    Ma H; Li N; Mo Z
    Cytokine; 2022 Nov; 159():156013. PubMed ID: 36067712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NSUN2 modified by SUMO-2/3 promotes gastric cancer progression and regulates mRNA m5C methylation.
    Hu Y; Chen C; Tong X; Chen S; Hu X; Pan B; Sun X; Chen Z; Shi X; Hu Y; Shen X; Xue X; Lu M
    Cell Death Dis; 2021 Sep; 12(9):842. PubMed ID: 34504059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NFIB promotes cell growth, aggressiveness, metastasis and EMT of gastric cancer through the Akt/Stat3 signaling pathway.
    Wu C; Zhu X; Liu W; Ruan T; Wan W; Tao K
    Oncol Rep; 2018 Sep; 40(3):1565-1573. PubMed ID: 30015981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CircRNA_0005075 suppresses carcinogenesis via regulating miR-431/p53/epithelial-mesenchymal transition axis in gastric cancer.
    Wu J; Chen Z; Song Y; Zhu Y; Dou G; Shen X; Zhou Y; Jiang H; Li J; Peng Y
    Cell Biochem Funct; 2020 Oct; 38(7):932-942. PubMed ID: 32133664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-Type Lectin-Like Receptor 2 Suppresses AKT Signaling and Invasive Activities of Gastric Cancer Cells by Blocking Expression of Phosphoinositide 3-Kinase Subunits.
    Wang L; Yin J; Wang X; Shao M; Duan F; Wu W; Peng P; Jin J; Tang Y; Ruan Y; Sun Y; Gu J
    Gastroenterology; 2016 May; 150(5):1183-1195.e16. PubMed ID: 26855187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zinc-finger protein 331, a novel putative tumor suppressor, suppresses growth and invasiveness of gastric cancer.
    Yu J; Liang QY; Wang J; Cheng Y; Wang S; Poon TC; Go MY; Tao Q; Chang Z; Sung JJ
    Oncogene; 2013 Jan; 32(3):307-17. PubMed ID: 22370639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STAM2 knockdown inhibits proliferation, migration, and invasion by affecting the JAK2/STAT3 signaling pathway in gastric cancer.
    Yang Y; Zhang Q; Liang J; Yang M; Wang Z; Tang D; Wang D
    Acta Biochim Biophys Sin (Shanghai); 2021 May; 53(6):697-706. PubMed ID: 33778841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. M-phase phosphoprotein 8 promotes gastric cancer growth and metastasis via p53/Bcl-2 and EMT-related signaling pathways.
    Wang Y; Xiao H; Wang C; Wu H; He H; Yao C; Cui J; Li W
    J Cell Biochem; 2020 Mar; 121(3):2330-2342. PubMed ID: 31692032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-18a modulates P53 expression by targeting IRF2 in gastric cancer patients.
    Chen YJ; Wu H; Zhu JM; Li XD; Luo SW; Dong L; Liu TT; Shen XZ
    J Gastroenterol Hepatol; 2016 Jan; 31(1):155-63. PubMed ID: 26173586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. YAP1 enhances cell proliferation, migration, and invasion of gastric cancer in vitro and in vivo.
    Sun D; Li X; He Y; Li W; Wang Y; Wang H; Jiang S; Xin Y
    Oncotarget; 2016 Dec; 7(49):81062-81076. PubMed ID: 27835600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.